APO Research
Talk to an analyst

APO RESEARCH · REPORT

Orphan Drug Development

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Orphan Drug Development Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

1 May 2026196 pages

Choose your research edition.

Industry ResearchOrphan Drug Development Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal Orphan Drug Development Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Orphan Drug Development Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Orphan Drug Development Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Orphan Drug Development Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Orphan Drug Development market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Orphan Drug Development is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Orphan Drug Development is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Orphan Drug Development is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Orphan Drug Development is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Orphan Drug Development include Novartis, Roche, Celgene, BMS, Shire, Merck, J&J, Pfizer and Biogen, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Orphan Drug Development market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Orphan Drug Development and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Orphan Drug Development revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Orphan Drug Development market size, projected growth trends, production technologies, key applications, and end-use industries.

Orphan Drug Development Segment by Company

Novartis

Roche

Celgene

BMS

Shire

Merck

J&J

Pfizer

Biogen

Sanofi

AstraZeneca

Takeda

Orphan Drug Development Segment by Type

Pediatric Orphan Drugs

Adult Orphan Drugs

Orphan Drug Development Segment by Application

Congenital and Genetic Diseases

Tumors and Cancer

Endocrine Diseases

Others

Orphan Drug Development Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Orphan Drug Development market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Orphan Drug Development and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Orphan Drug Development.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Orphan Drug Development in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Orphan Drug Development industry.

Chapter 3: Detailed analysis of Orphan Drug Development companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Orphan Drug Developmentrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Orphan Drug Development Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Pediatric Orphan Drugs Table 3. Key Players of Adult Orphan Drugs Table 4. Global Orphan Drug Development Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Congenital and Genetic Diseases Table 6. Key Players of Tumors and Cancer Table 7. Key Players of Endocrine Diseases Table 8. Key Players of Others Table 9. Global Orphan Drug Development Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 10. Global Orphan Drug Development Market Size by Region (2021-2026) & (US$ Million) Table 11. Global Orphan Drug Development Market Share by Region (2021-2026) Table 12. Global Orphan Drug Development Market Size by Region (2027-2032) & (US$ Million) Table 13. Global Orphan Drug Development Market Share by Region (2027-2032) Table 14. Orphan Drug Development Industry Trends Table 15. Orphan Drug Development Industry Drivers Table 16. Orphan Drug Development Industry Opportunities and Challenges Table 17. Orphan Drug Development Industry Restraints Table 18. Global Orphan Drug Development Revenue by Company (US$ Million) & (2021-2026) Table 19. Global Orphan Drug Development Revenue Market Share by Company (2021-2026) Table 20. Global Orphan Drug Development Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 21. Global Orphan Drug Development Key Company Head Office and Area Served Table 22. Global Orphan Drug Development Company, Product Type & Application Table 23. Global Orphan Drug Development Company Establishment Date Table 24. Global Company Market Concentration Ratio (CR5 and HHI) Table 25. Global Orphan Drug Development by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 26. Global Orphan Drug Development Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Orphan Drug Development Market Size by Type (2021-2026) & (US$ Million) Table 28. Global Orphan Drug Development Market Size by Type (2027-2032) & (US$ Million) Table 29. Global Orphan Drug Development Revenue Market Share by Type (2021-2026) Table 30. Global Orphan Drug Development Revenue Market Share by Type (2027-2032) Table 31. Global Orphan Drug Development Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Orphan Drug Development Market Size by Application (2021-2026) & (US$ Million) Table 33. Global Orphan Drug Development Market Size by Application (2027-2032) & (US$ Million) Table 34. Global Orphan Drug Development Revenue Market Share by Application (2021-2026) Table 35. Global Orphan Drug Development Revenue Market Share by Application (2027-2032) Table 36. Novartis Company Information Table 37. Novartis Business Overview Table 38. Novartis Orphan Drug Development Revenue and Gross Margin (US$ Million) & (2021-2026) Table 39. Novartis Orphan Drug Development Product Portfolio Table 40. Novartis Recent Development Table 41. Roche Company Information Table 42. Roche Business Overview Table 43. Roche Orphan Drug Development Revenue and Gross Margin (US$ Million) & (2021-2026) Table 44. Roche Orphan Drug Development Product Portfolio Table 45. Roche Recent Development Table 46. Celgene Company Information Table 47. Celgene Business Overview Table 48. Celgene Orphan Drug Development Revenue and Gross Margin (US$ Million) & (2021-2026) Table 49. Celgene Orphan Drug Development Product Portfolio Table 50. Celgene Recent Development Table 51. BMS Company Information Table 52. BMS Business Overview Table 53. BMS Orphan Drug Development Revenue and Gross Margin (US$ Million) & (2021-2026) Table 54. BMS Orphan Drug Development Product Portfolio Table 55. BMS Recent Development Table 56. Shire Company Information Table 57. Shire Business Overview Table 58. Shire Orphan Drug Development Revenue and Gross Margin (US$ Million) & (2021-2026) Table 59. Shire Orphan Drug Development Product Portfolio Table 60. Shire Recent Development Table 61. Merck Company Information Table 62. Merck Business Overview Table 63. Merck Orphan Drug Development Revenue and Gross Margin (US$ Million) & (2021-2026) Table 64. Merck Orphan Drug Development Product Portfolio Table 65. Merck Recent Development Table 66. J&J Company Information Table 67. J&J Business Overview Table 68. J&J Orphan Drug Development Revenue and Gross Margin (US$ Million) & (2021-2026) Table 69. J&J Orphan Drug Development Product Portfolio Table 70. J&J Recent Development Table 71. Pfizer Company Information Table 72. Pfizer Business Overview Table 73. Pfizer Orphan Drug Development Revenue and Gross Margin (US$ Million) & (2021-2026) Table 74. Pfizer Orphan Drug Development Product Portfolio Table 75. Pfizer Recent Development Table 76. Biogen Company Information Table 77. Biogen Business Overview Table 78. Biogen Orphan Drug Development Revenue and Gross Margin (US$ Million) & (2021-2026) Table 79. Biogen Orphan Drug Development Product Portfolio Table 80. Biogen Recent Development Table 81. Sanofi Company Information Table 82. Sanofi Business Overview Table 83. Sanofi Orphan Drug Development Revenue and Gross Margin (US$ Million) & (2021-2026) Table 84. Sanofi Orphan Drug Development Product Portfolio Table 85. Sanofi Recent Development Table 86. AstraZeneca Company Information Table 87. AstraZeneca Business Overview Table 88. AstraZeneca Orphan Drug Development Revenue and Gross Margin (US$ Million) & (2021-2026) Table 89. AstraZeneca Orphan Drug Development Product Portfolio Table 90. AstraZeneca Recent Development Table 91. Takeda Company Information Table 92. Takeda Business Overview Table 93. Takeda Orphan Drug Development Revenue and Gross Margin (US$ Million) & (2021-2026) Table 94. Takeda Orphan Drug Development Product Portfolio Table 95. Takeda Recent Development Table 96. North America Orphan Drug Development Market Size by Type (2021-2026) & (US$ Million) Table 97. North America Orphan Drug Development Market Size by Type (2027-2032) & (US$ Million) Table 98. North America Orphan Drug Development Market Size by Application (2021-2026) & (US$ Million) Table 99. North America Orphan Drug Development Market Size by Application (2027-2032) & (US$ Million) Table 100. North America Orphan Drug Development Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 101. North America Orphan Drug Development Market Size by Country (2021-2026) Table 102. North America Orphan Drug Development Market Size by Country (2027-2032) Table 103. Europe Orphan Drug Development Market Size by Type (2021-2026) & (US$ Million) Table 104. Europe Orphan Drug Development Market Size by Type (2027-2032) & (US$ Million) Table 105. Europe Orphan Drug Development Market Size by Application (2021-2026) & (US$ Million) Table 106. Europe Orphan Drug Development Market Size by Application (2027-2032) & (US$ Million) Table 107. Europe Orphan Drug Development Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 108. Europe Orphan Drug Development Market Size by Country (2021-2026) Table 109. Europe Orphan Drug Development Market Size by Country (2027-2032) Table 110. China Orphan Drug Development Market Size by Type (2021-2026) & (US$ Million) Table 111. China Orphan Drug Development Market Size by Type (2027-2032) & (US$ Million) Table 112. China Orphan Drug Development Market Size by Application (2021-2026) & (US$ Million) Table 113. China Orphan Drug Development Market Size by Application (2027-2032) & (US$ Million) Table 114. Asia Orphan Drug Development Market Size by Type (2021-2026) & (US$ Million) Table 115. Asia Orphan Drug Development Market Size by Type (2027-2032) & (US$ Million) Table 116. Asia Orphan Drug Development Market Size by Application (2021-2026) & (US$ Million) Table 117. Asia Orphan Drug Development Market Size by Application (2027-2032) & (US$ Million) Table 118. Asia Orphan Drug Development Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 119. Asia Orphan Drug Development Market Size by Country (2021-2026) Table 120. Asia Orphan Drug Development Market Size by Country (2027-2032) Table 121. South America, Middle East & Africa Orphan Drug Development Market Size by Type (2021-2026) & (US$ Million) Table 122. South America, Middle East & Africa Orphan Drug Development Market Size by Type (2027-2032) & (US$ Million) Table 123. South America, Middle East & Africa Orphan Drug Development Market Size by Application (2021-2026) & (US$ Million) Table 124. South America, Middle East & Africa Orphan Drug Development Market Size by Application (2027-2032) & (US$ Million) Table 125. South America, Middle East & Africa Orphan Drug Development Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 126. South America, Middle East & Africa Orphan Drug Development Market Size by Country (2021-2026) Table 127. South America, Middle East & Africa Orphan Drug Development Market Size by Country (2027-2032) Table 128. Research Programs/Design for This Report Table 129. Authors List of This Report Table 130. Secondary Sources Table 131. Primary Sources List of Figures Figure 1. Orphan Drug Development Product Image Figure 2. Global Orphan Drug Development Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Orphan Drug Development Market Share by Type: 2025 VS 2032 Figure 4. Pediatric Orphan Drugs Image Figure 5. Adult Orphan Drugs Image Figure 6. Global Orphan Drug Development Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 7. Global Orphan Drug Development Market Share by Application: 2025 VS 2032 Figure 8. Congenital and Genetic Diseases Image Figure 9. Tumors and Cancer Image Figure 10. Endocrine Diseases Image Figure 11. Others Image Figure 12. Global Orphan Drug Development Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Orphan Drug Development Market Size (2021-2032) & (US$ Million) Figure 14. Global Orphan Drug Development Market Share by Region: 2025 VS 2032 Figure 15. Years Considered Figure 16. Global Orphan Drug Development Market Share by Players in 2025 Figure 17. Global Top 5 and 10 Orphan Drug Development Players Market Share by Revenue in 2025 Figure 18. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 19. Global Orphan Drug Development Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Orphan Drug Development Revenue Market Share by Type (2021-2032) Figure 21. Global Orphan Drug Development Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Orphan Drug Development Revenue Market Share by Application (2021-2032) Figure 23. North America Orphan Drug Development Market Size (2021-2032) & (US$ Million) Figure 24. North America Orphan Drug Development Market Share by Type (2021-2032) Figure 25. North America Orphan Drug Development Market Share by Application (2021-2032) Figure 26. North America Orphan Drug Development Market Share by Country (2021-2032) Figure 27. United States Orphan Drug Development Market Size (2021-2032) & (US$ Million) Figure 28. Canada Orphan Drug Development Market Size (2021-2032) & (US$ Million) Figure 29. Mexico Orphan Drug Development Market Size (2021-2032) & (US$ Million) Figure 30. Europe Orphan Drug Development Market Size (2021-2032) & (US$ Million) Figure 31. Europe Orphan Drug Development Market Share by Type (2021-2032) Figure 32. Europe Orphan Drug Development Market Share by Application (2021-2032) Figure 33. Europe Orphan Drug Development Market Share by Country (2021-2032) Figure 34. Germany Orphan Drug Development Market Size (2021-2032) & (US$ Million) Figure 35. France Orphan Drug Development Market Size (2021-2032) & (US$ Million) Figure 36. U.K. Orphan Drug Development Market Size (2021-2032) & (US$ Million) Figure 37. Italy Orphan Drug Development Market Size (2021-2032) & (US$ Million) Figure 38. Russia Orphan Drug Development Market Size (2021-2032) & (US$ Million) Figure 39. Nordic Countries Orphan Drug Development Market Size (2021-2032) & (US$ Million) Figure 40. China Orphan Drug Development Market Size (2021-2032) & (US$ Million) Figure 41. China Orphan Drug Development Market Share by Type (2021-2032) Figure 42. China Orphan Drug Development Market Share by Application (2021-2032) Figure 43. Asia Orphan Drug Development Market Size (2021-2032) & (US$ Million) Figure 44. Asia Orphan Drug Development Market Share by Type (2021-2032) Figure 45. Asia Orphan Drug Development Market Share by Application (2021-2032) Figure 46. Asia Orphan Drug Development Market Share by Country (2021-2032) Figure 47. Japan Orphan Drug Development Market Size (2021-2032) & (US$ Million) Figure 48. South Korea Orphan Drug Development Market Size (2021-2032) & (US$ Million) Figure 49. Taiwan Orphan Drug Development Market Size (2021-2032) & (US$ Million) Figure 50. Southeast Asia Orphan Drug Development Market Size (2021-2032) & (US$ Million) Figure 51. India Orphan Drug Development Market Size (2021-2032) & (US$ Million) Figure 52. Australia Orphan Drug Development Market Size (2021-2032) & (US$ Million) Figure 53. South America, Middle East & Africa Orphan Drug Development Market Size (2021-2032) & (US$ Million) Figure 54. South America, Middle East & Africa Orphan Drug Development Market Share by Type (2021-2032) Figure 55. South America, Middle East & Africa Orphan Drug Development Market Share by Application (2021-2032) Figure 56. South America, Middle East & Africa Orphan Drug Development Market Share by Country (2021-2032) Figure 57. Brazil Orphan Drug Development Market Size (2021-2032) & (US$ Million) Figure 58. South Africa Orphan Drug Development Market Size (2021-2032) & (US$ Million) Figure 59. Saudi Arabia Orphan Drug Development Market Size (2021-2032) & (US$ Million) Figure 60. Turkey Orphan Drug Development Market Size (2021-2032) & (US$ Million) Figure 61. Argentina Orphan Drug Development Market Size (2021-2032) & (US$ Million) Figure 62. UAE Orphan Drug Development Market Size (2021-2032) & (US$ Million) Figure 63. Egypt Orphan Drug Development Market Size (2021-2032) & (US$ Million) Figure 64. Chile Orphan Drug Development Market Size (2021-2032) & (US$ Million) Figure 65. Research Process Figure 66. Key Executives Interviewed

Scope & coverage.

Types
  • Pediatric Orphan Drugs
  • Adult Orphan Drugs
Applications
  • Congenital and Genetic Diseases
  • Tumors and Cancer
  • Endocrine Diseases
  • Others
Companies covered
  • Novartis
  • Roche
  • Celgene
  • BMS
  • Shire
  • Merck
  • J&J
  • Pfizer
  • Biogen
  • Sanofi
  • AstraZeneca
  • Takeda

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Orphan Drug Development Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Pediatric Orphan Drugs
  5. 1.2.3 Adult Orphan Drugs
  6. 1.3 Market Analysis by Application
  7. 1.3.1 Global Orphan Drug Development Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  8. 1.3.2 Congenital and Genetic Diseases
  9. 1.3.3 Tumors and Cancer
  10. 1.3.4 Endocrine Diseases
  11. 1.3.5 Others
  12. 1.4 Global Market Growth Prospects
  13. 1.5 Global Orphan Drug Development Growth Trends by Region
  14. 1.5.1 Global Orphan Drug Development Market Size by Region: 2021 VS 2025 VS 2032
  15. 1.5.2 Orphan Drug Development Market Size by Region (2021-2026)
  16. 1.5.3 Orphan Drug Development Market Size by Region (2027-2032)
  17. 1.6 Assumptions and Limitations
  18. 1.7 Study Goals and Objectives
  19. 1.8 Years Considered
2 Global Orphan Drug Development Market Dynamics
  1. 2.1 Orphan Drug Development Industry Trends
  2. 2.2 Orphan Drug Development Industry Drivers
  3. 2.3 Orphan Drug Development Industry Opportunities and Challenges
  4. 2.4 Orphan Drug Development Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Orphan Drug Development Revenue by Company (2021-2026)
  2. 3.2 Global Orphan Drug Development Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Orphan Drug Development Key Company Head office and Area Served
  4. 3.4 Global Orphan Drug Development Company, Product Type & Application
  5. 3.5 Global Orphan Drug Development Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Orphan Drug Development Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Orphan Drug Development Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Orphan Drug Development Tier 1, Tier 2, and Tier 3
4 Orphan Drug Development Market by Type
  1. 4.1 Global Orphan Drug Development Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Orphan Drug Development Market Size by Type (2021-2032)
  3. 4.3 Global Orphan Drug Development Market Size Share by Type (2021-2032)
5 Orphan Drug Development Market by Application
  1. 5.1 Global Orphan Drug Development Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Orphan Drug Development Market Size by Application (2021-2032)
  3. 5.3 Global Orphan Drug Development Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Novartis
  2. 6.1.1 Novartis Company Information
  3. 6.1.2 Novartis Business Overview
  4. 6.1.3 Novartis Orphan Drug Development Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Novartis Orphan Drug Development Product Portfolio
  6. 6.1.5 Novartis Recent Developments
  7. 6.2 Roche
  8. 6.2.1 Roche Company Information
  9. 6.2.2 Roche Business Overview
  10. 6.2.3 Roche Orphan Drug Development Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Roche Orphan Drug Development Product Portfolio
  12. 6.2.5 Roche Recent Developments
  13. 6.3 Celgene
  14. 6.3.1 Celgene Company Information
  15. 6.3.2 Celgene Business Overview
  16. 6.3.3 Celgene Orphan Drug Development Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Celgene Orphan Drug Development Product Portfolio
  18. 6.3.5 Celgene Recent Developments
  19. 6.4 BMS
  20. 6.4.1 BMS Company Information
  21. 6.4.2 BMS Business Overview
  22. 6.4.3 BMS Orphan Drug Development Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 BMS Orphan Drug Development Product Portfolio
  24. 6.4.5 BMS Recent Developments
  25. 6.5 Shire
  26. 6.5.1 Shire Company Information
  27. 6.5.2 Shire Business Overview
  28. 6.5.3 Shire Orphan Drug Development Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Shire Orphan Drug Development Product Portfolio
  30. 6.5.5 Shire Recent Developments
  31. 6.6 Merck
  32. 6.6.1 Merck Company Information
  33. 6.6.2 Merck Business Overview
  34. 6.6.3 Merck Orphan Drug Development Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Merck Orphan Drug Development Product Portfolio
  36. 6.6.5 Merck Recent Developments
  37. 6.7 J&J
  38. 6.7.1 J&J Company Information
  39. 6.7.2 J&J Business Overview
  40. 6.7.3 J&J Orphan Drug Development Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 J&J Orphan Drug Development Product Portfolio
  42. 6.7.5 J&J Recent Developments
  43. 6.8 Pfizer
  44. 6.8.1 Pfizer Company Information
  45. 6.8.2 Pfizer Business Overview
  46. 6.8.3 Pfizer Orphan Drug Development Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 Pfizer Orphan Drug Development Product Portfolio
  48. 6.8.5 Pfizer Recent Developments
  49. 6.9 Biogen
  50. 6.9.1 Biogen Company Information
  51. 6.9.2 Biogen Business Overview
  52. 6.9.3 Biogen Orphan Drug Development Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 Biogen Orphan Drug Development Product Portfolio
  54. 6.9.5 Biogen Recent Developments
  55. 6.10 Sanofi
  56. 6.10.1 Sanofi Company Information
  57. 6.10.2 Sanofi Business Overview
  58. 6.10.3 Sanofi Orphan Drug Development Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 Sanofi Orphan Drug Development Product Portfolio
  60. 6.10.5 Sanofi Recent Developments
  61. 6.11 AstraZeneca
  62. 6.11.1 AstraZeneca Company Information
  63. 6.11.2 AstraZeneca Business Overview
  64. 6.11.3 AstraZeneca Orphan Drug Development Revenue and Gross Margin (US$ Million) & (2021-2026)
  65. 6.11.4 AstraZeneca Orphan Drug Development Product Portfolio
  66. 6.11.5 AstraZeneca Recent Developments
  67. 6.12 Takeda
  68. 6.12.1 Takeda Company Information
  69. 6.12.2 Takeda Business Overview
  70. 6.12.3 Takeda Orphan Drug Development Revenue and Gross Margin (US$ Million) & (2021-2026)
  71. 6.12.4 Takeda Orphan Drug Development Product Portfolio
  72. 6.12.5 Takeda Recent Developments
7 North America
  1. 7.1 North America Orphan Drug Development Market Size (2021-2032)
  2. 7.2 North America Orphan Drug Development Market Size by Type
  3. 7.2.1 North America Orphan Drug Development Market Size by Type (2021-2026)
  4. 7.2.2 North America Orphan Drug Development Market Size by Type (2027-2032)
  5. 7.2.3 North America Orphan Drug Development Market Share by Type (2021-2032)
  6. 7.3 North America Orphan Drug Development Market Size by Application
  7. 7.3.1 North America Orphan Drug Development Market Size by Application (2021-2026)
  8. 7.3.2 North America Orphan Drug Development Market Size by Application (2027-2032)
  9. 7.3.3 North America Orphan Drug Development Market Share by Application (2021-2032)
  10. 7.4 North America Orphan Drug Development Market Size by Country
  11. 7.4.1 North America Orphan Drug Development Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Orphan Drug Development Market Size by Country (2021-2026)
  13. 7.4.3 North America Orphan Drug Development Market Size by Country (2027-2032)
  14. 7.4.4 North America Orphan Drug Development Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Orphan Drug Development Market Size (2021-2032)
  2. 8.2 Europe Orphan Drug Development Market Size by Type
  3. 8.2.1 Europe Orphan Drug Development Market Size by Type (2021-2026)
  4. 8.2.2 Europe Orphan Drug Development Market Size by Type (2027-2032)
  5. 8.2.3 Europe Orphan Drug Development Market Share by Type (2021-2032)
  6. 8.3 Europe Orphan Drug Development Market Size by Application
  7. 8.3.1 Europe Orphan Drug Development Market Size by Application (2021-2026)
  8. 8.3.2 Europe Orphan Drug Development Market Size by Application (2027-2032)
  9. 8.3.3 Europe Orphan Drug Development Market Share by Application (2021-2032)
  10. 8.4 Europe Orphan Drug Development Market Size by Country
  11. 8.4.1 Europe Orphan Drug Development Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Orphan Drug Development Market Size by Country (2021-2026)
  13. 8.4.3 Europe Orphan Drug Development Market Size by Country (2027-2032)
  14. 8.4.4 Europe Orphan Drug Development Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Orphan Drug Development Market Size (2021-2032)
  2. 9.2 China Orphan Drug Development Market Size by Type
  3. 9.2.1 China Orphan Drug Development Market Size by Type (2021-2026)
  4. 9.2.2 China Orphan Drug Development Market Size by Type (2027-2032)
  5. 9.2.3 China Orphan Drug Development Market Share by Type (2021-2032)
  6. 9.3 China Orphan Drug Development Market Size by Application
  7. 9.3.1 China Orphan Drug Development Market Size by Application (2021-2026)
  8. 9.3.2 China Orphan Drug Development Market Size by Application (2027-2032)
  9. 9.3.3 China Orphan Drug Development Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Orphan Drug Development Market Size (2021-2032)
  2. 10.2 Asia Orphan Drug Development Market Size by Type
  3. 10.2.1 Asia Orphan Drug Development Market Size by Type (2021-2026)
  4. 10.2.2 Asia Orphan Drug Development Market Size by Type (2027-2032)
  5. 10.2.3 Asia Orphan Drug Development Market Share by Type (2021-2032)
  6. 10.3 Asia Orphan Drug Development Market Size by Application
  7. 10.3.1 Asia Orphan Drug Development Market Size by Application (2021-2026)
  8. 10.3.2 Asia Orphan Drug Development Market Size by Application (2027-2032)
  9. 10.3.3 Asia Orphan Drug Development Market Share by Application (2021-2032)
  10. 10.4 Asia Orphan Drug Development Market Size by Country
  11. 10.4.1 Asia Orphan Drug Development Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Orphan Drug Development Market Size by Country (2021-2026)
  13. 10.4.3 Asia Orphan Drug Development Market Size by Country (2027-2032)
  14. 10.4.4 Asia Orphan Drug Development Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Orphan Drug Development Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Orphan Drug Development Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Orphan Drug Development Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Orphan Drug Development Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Orphan Drug Development Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Orphan Drug Development Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Orphan Drug Development Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Orphan Drug Development Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Orphan Drug Development Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Orphan Drug Development Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Orphan Drug Development Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Orphan Drug Development Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Orphan Drug Development Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Orphan Drug Development Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst